Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.

<h4>Background</h4>Some 5%-15% of all women experience postpartum depression (PPD), which for many is their first psychiatric disorder. The purpose of this study was to estimate the incidence of postpartum affective disorder (AD), duration of treatment, and rate of subsequent postpartum...

Full description

Bibliographic Details
Main Authors: Marie-Louise H Rasmussen, Marin Strøm, Jan Wohlfahrt, Poul Videbech, Mads Melbye
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-09-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1002392
id doaj-24e0f0efecb64c29a8b05454ce77af97
record_format Article
spelling doaj-24e0f0efecb64c29a8b05454ce77af972021-04-21T18:34:29ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762017-09-01149e100239210.1371/journal.pmed.1002392Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.Marie-Louise H RasmussenMarin StrømJan WohlfahrtPoul VidebechMads Melbye<h4>Background</h4>Some 5%-15% of all women experience postpartum depression (PPD), which for many is their first psychiatric disorder. The purpose of this study was to estimate the incidence of postpartum affective disorder (AD), duration of treatment, and rate of subsequent postpartum AD and other affective episodes in a nationwide cohort of women with no prior psychiatric history.<h4>Methods and findings</h4>Linking information from several Danish national registers, we constructed a cohort of 457,317 primiparous mothers with first birth (and subsequent births) from 1 January 1996 to 31 December 2013 (a total of 789,068 births) and no prior psychiatric hospital contacts and/or use of antidepressants. These women were followed from 1 January 1996 to 31 December 2014. Postpartum AD was defined as use of antidepressants and/or hospital contact for PPD within 6 months after childbirth. The main outcome measures were risk of postpartum AD, duration of treatment, and recurrence risk. We observed 4,550 (0.6%) postpartum episodes of AD. The analyses of treatment duration showed that 1 year after the initiation of treatment for their first episode, 27.9% of women were still in treatment; after 4 years, 5.4%. The recurrence risk of postpartum AD for women with a PPD hospital contact after first birth was 55.4 per 100 person-years; for women with postpartum antidepressant medication after first birth, it was 35.0 per 100 person-years. The rate of postpartum AD after second birth for women with no history of postpartum AD was 1.2 per 100 person-years. After adjusting for year of birth and mother's age, women with PPD hospital contact after first birth had a 46.4 times higher rate (95% CI 31.5-68.4) and women with postpartum antidepressant medication after their first birth had a 26.9 times higher rate (95% CI 21.9-33.2) of a recurrent postpartum episode after their second birth compared to women with no postpartum AD history. Limitations include the use of registry data to identify cases and limited confounder control.<h4>Conclusions</h4>In this study, an episode of postpartum AD was observed for 0.6% of childbirths among women with no prior psychiatric history. The observed episodes were characterized by a relatively short treatment duration, yet the women had a notably high rate of later AD and recurrent episodes of postpartum AD. The recurrence risk of postpartum AD was markedly higher among women with PPD hospital contact after first birth compared to women with postpartum antidepressant medication after first birth. Our results underline the necessity of measures targeted at specific vulnerable groups, such as women who experience PPD as a first psychiatric episode.https://doi.org/10.1371/journal.pmed.1002392
collection DOAJ
language English
format Article
sources DOAJ
author Marie-Louise H Rasmussen
Marin Strøm
Jan Wohlfahrt
Poul Videbech
Mads Melbye
spellingShingle Marie-Louise H Rasmussen
Marin Strøm
Jan Wohlfahrt
Poul Videbech
Mads Melbye
Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.
PLoS Medicine
author_facet Marie-Louise H Rasmussen
Marin Strøm
Jan Wohlfahrt
Poul Videbech
Mads Melbye
author_sort Marie-Louise H Rasmussen
title Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.
title_short Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.
title_full Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.
title_fullStr Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.
title_full_unstemmed Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.
title_sort risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: a population-based cohort study.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2017-09-01
description <h4>Background</h4>Some 5%-15% of all women experience postpartum depression (PPD), which for many is their first psychiatric disorder. The purpose of this study was to estimate the incidence of postpartum affective disorder (AD), duration of treatment, and rate of subsequent postpartum AD and other affective episodes in a nationwide cohort of women with no prior psychiatric history.<h4>Methods and findings</h4>Linking information from several Danish national registers, we constructed a cohort of 457,317 primiparous mothers with first birth (and subsequent births) from 1 January 1996 to 31 December 2013 (a total of 789,068 births) and no prior psychiatric hospital contacts and/or use of antidepressants. These women were followed from 1 January 1996 to 31 December 2014. Postpartum AD was defined as use of antidepressants and/or hospital contact for PPD within 6 months after childbirth. The main outcome measures were risk of postpartum AD, duration of treatment, and recurrence risk. We observed 4,550 (0.6%) postpartum episodes of AD. The analyses of treatment duration showed that 1 year after the initiation of treatment for their first episode, 27.9% of women were still in treatment; after 4 years, 5.4%. The recurrence risk of postpartum AD for women with a PPD hospital contact after first birth was 55.4 per 100 person-years; for women with postpartum antidepressant medication after first birth, it was 35.0 per 100 person-years. The rate of postpartum AD after second birth for women with no history of postpartum AD was 1.2 per 100 person-years. After adjusting for year of birth and mother's age, women with PPD hospital contact after first birth had a 46.4 times higher rate (95% CI 31.5-68.4) and women with postpartum antidepressant medication after their first birth had a 26.9 times higher rate (95% CI 21.9-33.2) of a recurrent postpartum episode after their second birth compared to women with no postpartum AD history. Limitations include the use of registry data to identify cases and limited confounder control.<h4>Conclusions</h4>In this study, an episode of postpartum AD was observed for 0.6% of childbirths among women with no prior psychiatric history. The observed episodes were characterized by a relatively short treatment duration, yet the women had a notably high rate of later AD and recurrent episodes of postpartum AD. The recurrence risk of postpartum AD was markedly higher among women with PPD hospital contact after first birth compared to women with postpartum antidepressant medication after first birth. Our results underline the necessity of measures targeted at specific vulnerable groups, such as women who experience PPD as a first psychiatric episode.
url https://doi.org/10.1371/journal.pmed.1002392
work_keys_str_mv AT marielouisehrasmussen risktreatmentdurationandrecurrenceriskofpostpartumaffectivedisorderinwomenwithnopriorpsychiatrichistoryapopulationbasedcohortstudy
AT marinstrøm risktreatmentdurationandrecurrenceriskofpostpartumaffectivedisorderinwomenwithnopriorpsychiatrichistoryapopulationbasedcohortstudy
AT janwohlfahrt risktreatmentdurationandrecurrenceriskofpostpartumaffectivedisorderinwomenwithnopriorpsychiatrichistoryapopulationbasedcohortstudy
AT poulvidebech risktreatmentdurationandrecurrenceriskofpostpartumaffectivedisorderinwomenwithnopriorpsychiatrichistoryapopulationbasedcohortstudy
AT madsmelbye risktreatmentdurationandrecurrenceriskofpostpartumaffectivedisorderinwomenwithnopriorpsychiatrichistoryapopulationbasedcohortstudy
_version_ 1714664660383301632